Harvard Bioscience
Stock Forecast, Prediction & Price Target

Harvard Bioscience Financial Estimates

Harvard Bioscience Revenue Estimates

Harvard Bioscience EBITDA Estimates

Harvard Bioscience Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$118.90M
 
N/A
$113.33M
 
-4.68%
$112.25M
 
-0.95%
Avg: $124.05M
Low: $123.54M
High: $124.55M
avg. 10.51%
Avg: $138M
Low: $137.43M
High: $138.56M
avg. 11.24%
Net Income
 
% change YoY
$-288K
 
N/A
$-9.51M
 
-3204.16%
$-3.41M
 
64.11%
Avg: $3.3M
Low: $2.96M
High: $3.39M
avg. 196.63%
Avg: $7.1M
Low: $6.32M
High: $6.39M
avg. 115.15%
EBITDA
 
% change YoY
$7.24M
 
N/A
$-1.04M
 
-114.41%
$8.03M
 
869.44%
Avg: $6.12M
Low: $6.09M
High: $6.14M
avg. -23.80%
Avg: $6.80M
Low: $6.78M
High: $6.83M
avg. 11.24%
EPS
 
% change YoY
-$0.01
 
N/A
-$0.23
 
-3139.43%
-$0.08
 
65%
Avg: $0.08
Low: $0.07
High: $0.08
avg. 193.16%
Avg: $0.15
Low: $0.15
High: $0.15
avg. 100%
Operating Expenses
 
% change YoY
$65.58M
 
N/A
$67.98M
 
3.65%
$64.49M
 
-5.13%
Avg: $51.78M
Low: $51.57M
High: $51.99M
avg. -19.70%
Avg: $57.60M
Low: $57.37M
High: $57.84M
avg. 11.24%

FAQ

What is Harvard Bioscience stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 155.89% in 2025-2026.

We have gathered data from 2 analysts. Their low estimate is 2.96M, average is 3.3M and high is 3.39M.

What is Harvard Bioscience stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 10.87% in 2025-2026.

We have gathered data from 1 analysts. Their low revenue estimate is $123.54M, average is $124.05M and high is $124.55M.

What is Harvard Bioscience stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 146.58% in 2025-2026.

We have gathered data from 2 analysts. Their low earnings per share estimate is $0.07, average is $0.08 and high is $0.08.